drugset / Trial / NCT02794922

Effectiveness of Vitamin B in Reducing Temporomandibular Joint Disorder Pain

NCT02794922

Phase 2 Completed 27 enrolled The University of Hong Kong
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine effectiveness of vitamin B in reducing temporomandibular joint disorder (TMD) pain. Patients will be randomised to receive the study drug or placebo. The study drug we are using is a combination of vitamin B1(thiamine mononitrate)-242.5mg; vitamin B6(pyridoxineHCl)-250mg, and vitamin B12(cyanocobalamin)-1mg. We will assess patient's pain level, range of jaw movement and record any side effects from using this medication.

Timeline

Start
2015-09
Primary completion
2016-06
Completion
2017-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin B Complex Unknown 1 mg
Subject Vitamin B Complex Unknown 242.5 mg
Subject Vitamin B Complex Unknown 250 mg